Drawing for TRUSTED ANTIVIRUS

USPTO serial 78123618

TRUSTED ANTIVIRUS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
BUCHANAN WILL, NORA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TRUSTED ANTIVIRUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009computer program for use in identifying and removing computer viruses; system for secure delivery of virus definition files over a global computer network using a public key infrastructure; system for secure delivery of virus definition files over a local computer network using a public key infrastructure; rating system for various systems used in identifying and removing computer virusesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 31, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 11, 2004CFITCASE FILE IN TICRS
Mar 29, 2004PETGPETITION TO REVIVE-GRANTED
Feb 24, 2004PETGPETITION TO REVIVE-GRANTED
Dec 31, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2003DOCKASSIGNED TO EXAMINER
Oct 24, 2003PETLCOMMUNICATION RECEIVED FROM PETITIONER
Oct 24, 2003MAILPAPER RECEIVED
Oct 23, 2003FAXXFAX RECEIVED
Sep 25, 2003PINMINCOMPLETE PETITION NOTICE MAILED
Jun 30, 2003PETRPETITION TO REVIVE-RECEIVED
Jun 30, 2003MAILPAPER RECEIVED
Jun 23, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 6, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 13, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2002DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance